CervoMed (CRVO) FCF Margin (2011 - 2025)
CervoMed (CRVO) reported FCF Margin of -75357.54% for Q4 2025, down 74985.16 percentage points from -372.38% a year earlier and down 73353.25 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) FCF Margin (2011 - 2025) Analysis & Trends
For FY2025, CervoMed posted FCF Margin of -585.30%, down 415.54 percentage points from FY2024.
- By year, FCF Margin came in at -169.76% in FY2024 (-65.49 pp) and -104.27% in FY2023.
- The Q4 2025 figure ranks as the lowest quarterly FCF Margin in data going back to Q3 2011.
- Year over year, FCF Margin has now declined in each of the last six quarters, with an average year-over-year change of -9689.77 percentage points over the last eight quarters.
- The high point for year-over-year FCF Margin in five years was Q2 2024 (a gain of 47.12 percentage points); the low point was Q4 2025 (a drop of 74985.16 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -2004.29% (Q3 2025), -370.63% (Q2 2025) and -203.10% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | CervoMed | 23.77 Mn | -62.25 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -75,357.54% |
| Sep 30, 2025 | -2,004.29% |
| Jun 30, 2025 | -370.63% |
| Mar 31, 2025 | -203.10% |
| Dec 31, 2024 | -372.38% |
| Sep 30, 2024 | -250.27% |
| Jun 30, 2024 | -66.94% |
| Mar 31, 2024 | -60.65% |
| Dec 31, 2023 | -101.92% |
| Sep 30, 2023 | -96.14% |
| Jun 30, 2023 | -114.06% |
| Mar 31, 2023 | -105.26% |
| Jun 30, 2022 | -7,236.08% |
| Mar 31, 2022 | -17,008.21% |
| Sep 30, 2021 | -5,861.82% |
| Jun 30, 2021 | -6,024.85% |
| Mar 31, 2021 | -12,807.72% |
| Dec 31, 2020 | -13,572.38% |
| Sep 30, 2020 | -12,007.03% |
| Jun 30, 2020 | -12,131.79% |
API Access
CervoMed FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();